IP Library Patent Application 12432994
Patent Application
App. No. 12/432,994

TISSUE ENGINEERED BLOOD VESSELS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/432,994
Abstract

Compositions and methods of using tissue engineered blood vessels to repair and regenerate blood vessels of patients with vascular disease are disclosed.

Claims (27)

1 . A tubular construct for a tissue engineered blood vessel comprising a scaffold comprising poly(p-dioxanone) and one or more or of cells, cell sheets, cell lysate and minced tissue.

2 . The tubular construct of claim 1 wherein the scaffold further comprises collagen.

3 . The tubular construct of claim 1 wherein the cells are selected from the group consisting of endothelial cells, smooth muscle cells, fibrobasts, human umbilical cord derived cells and combinations thereof.

4 . A method of making a tissue engineered blood vessel comprising the steps of:

a. Providing a tubular shaped scaffold comprising poly(p-dioxanone);

b. Seeding said scaffold with one or more cells selected from the group consisting of endothelial cells, smooth muscle cells, fibroblasts and human umbilical cord-derived cells; and

c. Culturing the cell seeded scaffold in a bioreactor.

5 . A method of making a tissue engineered blood vessel comprising the steps of:

a. Providing a tubular shaped scaffold comprising poly(p-dioxanone);

b. Wrapping said scaffold with a human umbilical cord-derived cell sheet; and

c. Culturing the cell sheet wrapped scaffold in a bioreactor.

6 . A method of making a tissue engineered blood vessel comprising the steps of:

a. Providing a tubular shaped scaffold comprising poly(p-dioxanone);

b. Applying said scaffold with minced muscle tissue and minced endothelial tissue; and

c. Culturing the minced tissue scaffold in a bioreactor.

7 . A method of making a tissue engineered blood vessel comprising the steps of:

a. Providing a tubular shaped scaffold comprising poly(p-dioxanone);

b. Applying said scaffold with cell lysate; and then

c. Lyophilizing the scaffold.

8 . The method of claim 7 further comprising the steps of:

a. applying one or more of cells and minced tissue to the cell lysate scaffold; and

b. culturing the cell lysate scaffold having one or more of cells and minced tissue in a bioreactor.

9 . A method of making a tissue engineered blood vessel comprising the steps of:

a. Providing a scaffold comprising poly(p-dioxanone);

b. Seeding said scaffold sheet with cells;

c. Rolling said seeded sheet into a tube; and

d. Culturing the tube in a bioreactor.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2025
From: CARDINAL HEALTH SWITZERLAND 515 GMBH; CARDINAL HEALTH 529, LLC; CORDIS CORPORATION; FLEXIBLE STENTING SOLUTIONS, INC
To: CORDIS US CORP
Reel/Frame 072987/0675 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2017
From: CORDIS CORPORATION
To: CARDINAL HEALTH SWITZERLAND 515 GMBH
Reel/Frame 042169/0662 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2013
From: ADVANCED TECHNOLOGIES AND REGENERATIVE MEDICINE, LLC
To: CORDIS CORPORATION
Reel/Frame 029595/0899 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2012
From: ADVANCED TECHNOLOGIES AND REGENERATIVE MEDICINE, LLC
To: CORDIS CORPORATION
Reel/Frame 029496/0405 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2011
From: ETHICON, INC.
To: ADVANCED TECHNOLOGIES AND REGENERATIVE MEDICINE, LLC
Reel/Frame 026286/0530 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2009
From: COOPER, KEVIN; CHUN, IKSOO; COLTER, DAVID C.; DHANARAJ, SRIDEVI; GOSIEWSKA, ANNA; SEYDA, AGNIESZKA; FANG, CARRIE H.; YANG, CHUNLIN
To: ETHICON, INC.
Reel/Frame 022932/0365 →